Home/ Supplements/ Vitamin K/ Real Food K-2 200 mcg Maximum Strength

Real Food K-2 200 mcg Maximum Strength

product on market Softgel Capsule Swanson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Vitamin K-2 is supported by moderate to strong evidence for promoting bone health and supporting cardiovascular function by regulating calcium deposition. This ingredient helps direct calcium into the bone matrix and away from arterial walls. Research indicates it is generally safe for most individuals when taken as directed.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Real Food K-2 200 mcg Maximum Strength
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

200 mcg (167% DV)
1.7× RDA — within safe limits 275 studies (A:9, B:175)

Other Ingredients

Sunflower Oil Gelatin Glycerin Beeswax Dibasic Calcium Phosphate purified Water Sunflower Lecithin Caramel color
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take one softgel per day with water.

Warnings & Precautions

Warning: For adults only.

Consult your physician before using this or any product if you are pregnant or nursing, taking medication, especially blood-thinning medications, or have a medical condition.

Keep out of reach of children.

Do not use if seal is broken.

Contains soy and sulfites.

Formulation Notes

Natural Vitamin K-2 200 mcg per softgel

Contains soy and sulfites.

Additional Information

Store in a cool, dry place. Do not refrigerate.

Bone and cardiovascular health

Metadata

Product Details

UPC / SKU0 87614 02906 1
DSLD Entry Date2019-06-24
Product TypeVitamin
FormSoftgel Capsule
BrandSwanson
DSLD ID204282
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.